Look for Drugs and Conditions

PIMOZIDE

PIMOZIDE

It is a recently introduced diphenylbutyl piperidine derivative. It is a selective DA antagonist with little alpha adrenergic or cholinergic blocking activity. It produces a low incidence of dystonic reactions. Because of long duration of action (several days) after a single oral dose, it is considered good for maintenance therapy but not when psychomotor agitation is prominent.

Indications

Acute schizophrenia, chronic schizophrenia, manic excitement.


Dosage

Initially 1-2mg once daily.Maint. 2-6mg daily.


Contra-Indications

History of Cardiac arrhythmias. Prolonged Q-T interval.


Special Precautions

Expectant mothers, hepatic & renal impairment. Monitor E.C.G. prior to & during treatment. Epilepsy, Parkinson syndrome. Endogenous depression. Donot interact with cardioactive or neuroleptic agents. Electrolyte imbalance. Paediatrics: Not recommended below 12 years. Pregnancy: Safety not established. Lactation: Use with caution. Elderly: The dose to be reduced.


Side Effects

Extrapyramidal reactions, nervousness, irritability, insomnia, drowsiness, weakness, dizziness.


Drug Interactions

Potentiates CNS depressants like anaesthetics, alcohol, barbiturates, anti-histaminics and benzodiazepines. Propranolol and cimetidine decrease hepatic metabolism and increases efficacy and toxicity.


Ad 5